Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
| Company Name | Founded | Funding Stage | Amount | City |
|---|---|---|---|---|
| Relation Therapeutics | 2025 | Series Unknown | $26.0M | London |
| Opentrons | 2025 | Series D | $20.1M | Brooklyn |
| Phia | 2025 | Series A | $35.0M | New York |
| Radical Health | 2025 | Pre-Seed | $5.0M | San Francisco |
| Circulate | 2025 | Seed | Undisclosed | Seattle |
| Excelsior Sciences | 2025 | Series A | $70.0M | New York |
| Vinci | 2025 | Series A | $36.0M | Palo Alto |
| Point One Navigation | 2025 | Series C | $35.0M | San Francisco |
| Stuut | 2025 | Series A | $29.5M | New York |
| Peek | 2025 | Series D | $70.0M | San Francisco |
| # | Company | Stage | Amount | Location |
|---|---|---|---|---|
| 451 | Relation Therapeutics | Series Unknown | $26.0M | London, United Kingdom |
| 452 | Opentrons | Series D | $20.1M | Brooklyn, United States |
| 453 | Phia | Series A | $35.0M | New York, United States |
| 454 | Radical Health | Pre-Seed | $5.0M | San Francisco, United States |
| 455 | Circulate | Seed | Undisclosed | Seattle, United States |
| 456 | Excelsior Sciences | Series A | $70.0M | New York, United States |
| 457 | Vinci | Series A | $36.0M | Palo Alto, United States |
| 458 | Point One Navigation | Series C | $35.0M | San Francisco, United States |
| 459 | Stuut | Series A | $29.5M | New York, United States |
| 460 | Peek | Series D | $70.0M | San Francisco, United States |
Relation Therapeutics is a biotechnology company that focuses on humanizing drug discovery and development.
Opentrons is a life science company that develops pipetting robot technology designed to automate experiments.
Phia is AI-powered shopping agent that provides a tool for online shoppers to compare prices and discover better deals.
Radical platform reviews complex medical data to deliver clear, personalized insights that help guide cancer treatment decisions.
Circulate provides Therapeutic Plasma Exchange treatments that reverses aging and improve health outcomes.
Excelsior Sciences applies AI and automated chemistry to simplify small-molecule discovery and accelerate overall drug development.
Vinci utilizes generative artificial intelligence to create hardware design.
Point One Navigation provides centimeter-level precision positioning through its RTK corrections network.
Stuut provides an AI platform that automates accounts receivable work for companies.
Peek is a travel-tech platform designed for booking tours and provides software for tour and activity operators to manage their businesses.
Physical Intelligence is an AI company developing machine learning for robots and other physical devices.
Onepot AI offers automated synthesis of small molecules from basic building blocks using a unified, end-to-end process.
Automat offers robotic process automation for Chrome using GPT4 and computer vision.
Runlayer secures MCP AI deployments for enterprises using custom threat detection, fine-grained permissions, and full observability.
House Rx is a health technology platform focused on improving affordability and patient access to specialty medications.
Parallel develops systems for AIs to efficiently interact with the web.
Synchron is a bioelectronics medicine company that develops neuromodulation solutions for previously-untreatable nervous system conditions.
Reevo is an AI-native revenue operating system that integrates marketing, sales, and customer success into a unified platform.
Overture Life is a biotechnology company that develops automated technologies for assisted reproductive procedures.
Lava is a bitcoin lending platform that offers a self-custodial wallet for managing bitcoin finances.
Affirm is a financial technology services company that offers installment loans to consumers at the point of sale.
Mazama Energy is a geothermal operator and development firm committed to developing new techniques and technology for removing heat.
Rosebud AI Gamemaker. Create Games, Share and Play Instantly Craft Worlds with Words. Go from text description to code to game.
Anrok is a global sales tax solution platform that automates sales tax compliance for modern commerce.
Syntracts securely converts complex contracts into structured insights using privacy-first AI.
Khosla Ventures has invested in 783 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Khosla Ventures's top investment sectors include Artificial Intelligence (AI), Health Care, Information Technology, Biotechnology, Medical. The firm invests across 49 different industry categories.
Among tracked funding rounds, Affirm received $750.0M in a Post Ipo Debt round. Khosla Ventures's total known invested capital is $34.0B.
Khosla Ventures's average investment size is $55.2M across its portfolio of 783 companies.
Recent Khosla Ventures portfolio additions include Relation Therapeutics, Opentrons, Phia, Radical Health, Circulate. These companies were founded in 2020 or later.
Discover portfolio companies of other leading venture capital firms and investors.
View All Investors